Status:
COMPLETED
Developing a Team-Delivered Intervention for Smoking and Hazardous Drinking for Primary Care Veterans With Cardiovascular Diseases
Lead Sponsor:
VA Office of Research and Development
Conditions:
Cigarette Use
Alcohol Use Above Recommended Limits
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this study, the investigators are interested in learning how patients feel about and are impacted by a new approach for the primary care team to use to talk to patients about heart disease and heal...
Detailed Description
Many Veterans (30.4%) with cardiovascular diseases (CVDs) continue to engage in behaviors that increase risk of cardiovascular events and early mortality, such as smoking or hazardous drinking. While ...
Eligibility Criteria
Inclusion
- Veteran patients age 18 seen in PACT at the Buffalo and Syracuse VA Medical Center (VAMCs) and catchment areas
- Upcoming PACT appointment
- A diagnosis of cardiac disease, including coronary artery disease, hypertension, hyperlipidemia, OR ischemia
- Positive alcohol or tobacco use screen for at least two consecutive years (including most recent) for:
- a.Smoking (i.e., Answered "Yes" on the Annual Veteran's Health Administration (VHA) Tobacco Use Screening Questionnaire) AND/OR
- b.Hazardous drinking (Alcohol Use Disorders-Consumption \[AUD-C\] 4 for men or 3 for women)
- Currently smokes at least one cigarette per day OR currently scores in a range indicating hazardous drinking on the Alcohol Use Disorders Identification Test (AUDIT) OR both \[telephone screen\]
- Currently reports on 1 to 10 scale having no greater than high-moderate (defined as 8) intention (i.e., 7) to change their drinking and/or smoking behavior \[telephone screen\]
Exclusion
- Disorientation at time of eligibility (i.e., delirium, acute psychosis, dementia, severe intoxication) \[from the electronic medical record (EMR), telephone screen, or clinical judgment at the time of the in person appointment\]
- Unable to read or understand English \[telephone screen\]
- Non-Veteran status \[EMR\]
Key Trial Info
Start Date :
May 13 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2024
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT05275582
Start Date
May 13 2022
End Date
April 30 2024
Last Update
May 20 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Western New York Healthcare System, Buffalo, NY
Buffalo, New York, United States, 14215-1129
2
Syracuse VA Medical Center, Syracuse, NY
Syracuse, New York, United States, 13210